EyePoint Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Sanders Reginald J.

Jan 9 05:15

EyePoint Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Sanders Reginald J.

Jan 9 05:15

EyePoint Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Zaderej Karen L.

Jan 8 05:10

EyePoint Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Hassan Fred

Jan 8 05:10

EyePoint Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director ANDO GORAN

Jan 8 05:09

EyePoint Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Duty Stuart

Jan 8 05:09

EyePoint Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director DICICCO WENDY F

Jan 8 05:09

EyePoint Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Ribeiro Ramiro

Jan 8 05:09

EyePoint Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Elston George

Jan 8 05:09

EyePoint Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Lurker Nancy

Jan 8 05:09

EyePoint Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Landis John B.

Jan 8 05:09

EyePoint Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Duker Jay S.

Jan 8 05:09

EyePoint Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Cormorant Asset Management, LP(12.20%),Bihua Chen(12.20%)

Nov 15, 2024 04:11

EyePoint Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-T. ROWE PRICE ASSOCIATES, INC.(4.7%)

Nov 15, 2024 02:28

EyePoint Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(5.69%)

Nov 13, 2024 03:37

EyePoint Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Adage Capital Management, L.P.(7.08%),Robert Atchinson(7.08%), etc.

Nov 12, 2024 22:43

EyePoint Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(7.8%)

Nov 9, 2024 11:18

EyePoint Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-TCG Crossover GP II, LLC(5.2%),TCG Crossover Fund II, L.P.(5.2%), etc.

Nov 8, 2024 11:31

EyePoint Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Federated Hermes, Inc.(5.44%),Voting Shares Irrevocable Trust(5.44%), etc.

Nov 6, 2024 21:57

EyePoint Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(5.69%)

Nov 5, 2024 01:00